The Post-GWAS Era: From Association to Function

American Journal of Human Genetics

Volumn 102, Issue 5, 2018, Pages 717-730

  Gallagher, Michael D ^a,b   Chen Plotkin, Alice S ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

^b WHITEHEAD INSTITUTE FOR BIOMEDICAL RESEARCH   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FUNCTIONAL GENOMICS; GENE CONTROL; GENE EXPRESSION; GENE FUNCTION; GENE LOCUS; GENE TARGETING; GENETIC ASSOCIATION; GENETIC ASSOCIATION STUDY; GENETIC RISK; GENETIC TRAIT; HUMAN; NONHUMAN; PRIORITY JOURNAL; REVIEW; SINGLE NUCLEOTIDE POLYMORPHISM; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION; GENETICS; GENOME-WIDE ASSOCIATION STUDY; MOLECULAR GENETICS; QUANTITATIVE TRAIT LOCUS; RISK FACTOR;

GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; GENOME-WIDE ASSOCIATION STUDY; HUMANS; MOLECULAR SEQUENCE ANNOTATION; QUANTITATIVE TRAIT LOCI; RISK FACTORS;

EID: 85046349817     PISSN: 00029297     EISSN: 15376605     Source Type: Journal    
DOI: 10.1016/j.ajhg.2018.04.002     Document Type: Review

References (107)

1. Crick, F., Central dogma of molecular biology. Nature 227 (1970), 561–563.
2. Ghosh, S., Collins, F.S., The geneticist's approach to complex disease. Annu. Rev. Med. 47 (1996), 333–353.
3. Gusella, J.F., Wexler, N.S., Conneally, P.M., Naylor, S.L., Anderson, M.A., Tanzi, R.E., Watkins, P.C., Ottina, K., Wallace, M.R., Sakaguchi, A.Y., et al. A polymorphic DNA marker genetically linked to Huntington's disease. Nature 306 (1983), 234–238.
4. Hirschhorn, J.N., Genetic approaches to studying common diseases and complex traits. Pediatr. Res. 57 (2005), 74R–77R.
5. Johnson, G.C., Todd, J.A., Strategies in complex disease mapping. Curr. Opin. Genet. Dev. 10 (2000), 330–334.
6. Wood, A.R., Esko, T., Yang, J., Vedantam, S., Pers, T.H., Gustafsson, S., Chu, A.Y., Estrada, K., Luan, J., Kutalik, Z., et al. Electronic Medical Records and Genomics (eMEMERGEGE) Consortium MIGen Consortium PAGEGE Consortium, LifeLines Cohort Study. Defining the role of common variation in the genomic and biological architecture of adult human height. Nat. Genet. 46 (2014), 1173–1186.
7. Klein, R.J., Zeiss, C., Chew, E.Y., Tsai, J.Y., Sackler, R.S., Haynes, C., Henning, A.K., SanGiovanni, J.P., Mane, S.M., Mayne, S.T., et al. Complement factor H polymorphism in age-related macular degeneration. Science 308 (2005), 385–389.
8. Edwards, A.O., Ritter, R. 3rd, Abel, K.J., Manning, A., Panhuysen, C., Farrer, L.A., Complement factor H polymorphism and age-related macular degeneration. Science 308 (2005), 421–424.
9. Haines, J.L., Hauser, M.A., Schmidt, S., Scott, W.K., Olson, L.M., Gallins, P., Spencer, K.L., Kwan, S.Y., Noureddine, M., Gilbert, J.R., et al. Complement factor H variant increases the risk of age-related macular degeneration. Science 308 (2005), 419–421.
10. Edwards, S.L., Beesley, J., French, J.D., Dunning, A.M., Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 93 (2013), 779–797.
11. Welter, D., MacArthur, J., Morales, J., Burdett, T., Hall, P., Junkins, H., Klemm, A., Flicek, P., Manolio, T., Hindorff, L., Parkinson, H., The NHGRI GWAS Catalog, a curated resource of SNP-trait associations. Nucleic Acids Res. 42 (2014), D1001–D1006.
12. Gabriel, S.B., Schaffner, S.F., Nguyen, H., Moore, J.M., Roy, J., Blumenstiel, B., Higgins, J., DeFelice, M., Lochner, A., Faggart, M., et al. The structure of haplotype blocks in the human genome. Science 296 (2002), 2225–2229.
13. Schaub, M.A., Boyle, A.P., Kundaje, A., Batzoglou, S., Snyder, M., Linking disease associations with regulatory information in the human genome. Genome Res. 22 (2012), 1748–1759.
14. Maurano, M.T., Humbert, R., Rynes, E., Thurman, R.E., Haugen, E., Wang, H., Reynolds, A.P., Sandstrom, R., Qu, H., Brody, J., et al. Systematic localization of common disease-associated variation in regulatory DNA. Science 337 (2012), 1190–1195.
15. Lelli, K.M., Slattery, M., Mann, R.S., Disentangling the many layers of eukaryotic transcriptional regulation. Annu. Rev. Genet. 46 (2012), 43–68.
16. Farh, K.K., Marson, A., Zhu, J., Kleinewietfeld, M., Housley, W.J., Beik, S., Shoresh, N., Whitton, H., Ryan, R.J., Shishkin, A.A., et al. Genetic and epigenetic fine mapping of causal autoimmune disease variants. Nature 518 (2015), 337–343.
17. Albert, F.W., Kruglyak, L., The role of regulatory variation in complex traits and disease. Nat. Rev. Genet. 16 (2015), 197–212.
18. Raj, T., Rothamel, K., Mostafavi, S., Ye, C., Lee, M.N., Replogle, J.M., Feng, T., Lee, M., Asinovski, N., Frohlich, I., et al. Polarization of the effects of autoimmune and neurodegenerative risk alleles in leukocytes. Science 344 (2014), 519–523.
19. Lu, Q., Powles, R.L., Abdallah, S., Ou, D., Wang, Q., Hu, Y., Lu, Y., Liu, W., Li, B., Mukherjee, S., et al. Systematic tissue-specific functional annotation of the human genome highlights immune-related DNA elements for late-onset Alzheimer's disease. PLoS Genet., 13, 2017, e1006933.
20. Pai, A.A., Pritchard, J.K., Gilad, Y., The genetic and mechanistic basis for variation in gene regulation. PLoS Genet., 11, 2015, e1004857.
21. Paraboschi, E.M., Rimoldi, V., Soldà, G., Tabaglio, T., Dall'Osso, C., Saba, E., Vigliano, M., Salviati, A., Leone, M., Benedetti, M.D., et al. Functional variations modulating PRKCA expression and alternative splicing predispose to multiple sclerosis. Hum. Mol. Genet. 23 (2014), 6746–6761.
22. Richardson, K., Nettleton, J.A., Rotllan, N., Tanaka, T., Smith, C.E., Lai, C.Q., Parnell, L.D., Lee, Y.C., Lahti, J., Lemaitre, R.N., et al. Gain-of-function lipoprotein lipase variant rs13702 modulates lipid traits through disruption of a microRNA-410 seed site. Am. J. Hum. Genet. 92 (2013), 5–14.
23. Wang, D., Poi, M.J., Sun, X., Gaedigk, A., Leeder, J.S., Sadee, W., Common CYP2D6 polymorphisms affecting alternative splicing and transcription: long-range haplotypes with two regulatory variants modulate CYP2D6 activity. Hum. Mol. Genet. 23 (2014), 268–278.
24. Zhang, L., Liu, Y., Song, F., Zheng, H., Hu, L., Lu, H., Liu, P., Hao, X., Zhang, W., Chen, K., Functional SNP in the microRNA-367 binding site in the 3'UTR of the calcium channel ryanodine receptor gene 3 (RYR3) affects breast cancer risk and calcification. Proc. Natl. Acad. Sci. USA 108 (2011), 13653–13658.
25. Kaplow, I.M., MacIsaac, J.L., Mah, S.M., McEwen, L.M., Kobor, M.S., Fraser, H.B., A pooling-based approach to mapping genetic variants associated with DNA methylation. Genome Res. 25 (2015), 907–917.
26. Hannon, E., Spiers, H., Viana, J., Pidsley, R., Burrage, J., Murphy, T.M., Troakes, C., Turecki, G., O'Donovan, M.C., Schalkwyk, L.C., et al. Methylation QTLs in the developing brain and their enrichment in schizophrenia risk loci. Nat. Neurosci. 19 (2016), 48–54.
27. Degner, J.F., Pai, A.A., Pique-Regi, R., Veyrieras, J.B., Gaffney, D.J., Pickrell, J.K., De Leon, S., Michelini, K., Lewellen, N., Crawford, G.E., et al. DNasecI sensitivity QTLs are a major determinant of human expression variation. Nature 482 (2012), 390–394.
28. Ding, Z., Ni, Y., Timmer, S.W., Lee, B.K., Battenhouse, A., Louzada, S., Yang, F., Dunham, I., Crawford, G.E., Lieb, J.D., et al. Quantitative genetics of CTCF binding reveal local sequence effects and different modes of X-chromosome association. PLoS Genet., 10, 2014, e1004798.
29. Tehranchi, A.K., Myrthil, M., Martin, T., Hie, B.L., Golan, D., Fraser, H.B., Pooled ChIP-seq links variation in transcription factor binding to complex disease risk. Cell 165 (2016), 730–741.
30. Dimas, A.S., Deutsch, S., Stranger, B.E., Montgomery, S.B., Borel, C., Attar-Cohen, H., Ingle, C., Beazley, C., Gutierrez Arcelus, M., Sekowska, M., et al. Common regulatory variation impacts gene expression in a cell type-dependent manner. Science 325 (2009), 1246–1250.
31. GTEx Consortium. Human genomics. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348 (2015), 648–660.
32. Tewhey, R., Kotliar, D., Park, D.S., Liu, B., Winnicki, S., Reilly, S.K., Andersen, K.G., Mikkelsen, T.S., Lander, E.S., Schaffner, S.F., Sabeti, P.C., Direct identification of hundreds of expression-modulating variants using a multiplexed reporter assay. Cell 165 (2016), 1519–1529.
33. Patwardhan, R.P., Hiatt, J.B., Witten, D.M., Kim, M.J., Smith, R.P., May, D., Lee, C., Andrie, J.M., Lee, S.I., Cooper, G.M., et al. Massively parallel functional dissection of mammalian enhancers in vivo. Nat. Biotechnol. 30 (2012), 265–270.
34. Harismendy, O., Notani, D., Song, X., Rahim, N.G., Tanasa, B., Heintzman, N., Ren, B., Fu, X.D., Topol, E.J., Rosenfeld, M.G., Frazer, K.A., 9p21 DNA variants associated with coronary artery disease impair interferon-γ signalling response. Nature 470 (2011), 264–268.
35. Musunuru, K., Strong, A., Frank-Kamenetsky, M., Lee, N.E., Ahfeldt, T., Sachs, K.V., Li, X., Li, H., Kuperwasser, N., Ruda, V.M., et al. From noncoding variant to phenotype via SORT1 at the 1p13 cholesterol locus. Nature 466 (2010), 714–719.
36. Verlaan, D.J., Berlivet, S., Hunninghake, G.M., Madore, A.M., Larivière, M., Moussette, S., Grundberg, E., Kwan, T., Ouimet, M., Ge, B., et al. Allele-specific chromatin remodeling in the ZPBP2/GSDMB/ORMDL3 locus associated with the risk of asthma and autoimmune disease. Am. J. Hum. Genet. 85 (2009), 377–393.
37. 1000 Genomes Project Consortium, Auton, A., Brooks, L.D., et al. A global reference for human genetic variation. Nature 526 (2015), 68–74.
38. International HapMap 3 Consortium, Altshuler, D.M., Gibbs, R.A., et al. Integrating common and rare genetic variation in diverse human populations. Nature 467 (2010), 52–58.
39. ENCODE Project Consortium. An integrated encyclopedia of DNA elements in the human genome. Nature 489 (2012), 57–74.
40. Kundaje, A., Meuleman, W., Ernst, J., Bilenky, M., Yen, A., Heravi-Moussavi, A., Kheradpour, P., Zhang, Z., Wang, J., Ziller, M.J., et al., Roadmap Epigenomics Consortium. Integrative analysis of 111 reference human epigenomes. Nature 518 (2015), 317–330.
41. Andersson, R., Gebhard, C., Miguel-Escalada, I., Hoof, I., Bornholdt, J., Boyd, M., Chen, Y., Zhao, X., Schmidl, C., Suzuki, T., et al. An atlas of active enhancers across human cell types and tissues. Nature 507 (2014), 455–461.
42. 1000 Genomes Project Consortium, Abecasis, G.R., Auton, A., et al. An integrated map of genetic variation from 1,092 human genomes. Nature 491 (2012), 56–65.
43. Glubb, D.M., Maranian, M.J., Michailidou, K., Pooley, K.A., Meyer, K.B., Kar, S., Carlebur, S., O'Reilly, M., Betts, J.A., Hillman, K.M., et al. GENICA Network kConFab Investigators, Norwegian Breast Cancer Study. Fine-scale mapping of the 5q11.2 breast cancer locus reveals at least three independent risk variants regulating MAP3K1. Am. J. Hum. Genet. 96 (2015), 5–20.
44. Wu, Y., Gao, H., Li, H., Tabara, Y., Nakatochi, M., Chiu, Y.F., Park, E.J., Wen, W., Adair, L.S., Borja, J.B., et al. A meta-analysis of genome-wide association studies for adiponectin levels in East Asians identifies a novel locus near WDR11-FGFR2. Hum. Mol. Genet. 23 (2014), 1108–1119.
45. Spain, S.L., Barrett, J.C., Strategies for fine-mapping complex traits. Hum. Mol. Genet. 24:R1 (2015), R111–R119.
46. Campbell, M.C., Tishkoff, S.A., African genetic diversity: implications for human demographic history, modern human origins, and complex disease mapping. Annu. Rev. Genomics Hum. Genet. 9 (2008), 403–433.
47. Guthridge, J.M., Lu, R., Sun, H., Sun, C., Wiley, G.B., Dominguez, N., Macwana, S.R., Lessard, C.J., Kim-Howard, X., Cobb, B.L., et al. Two functional lupus-associated BLK promoter variants control cell-type- and developmental-stage-specific transcription. Am. J. Hum. Genet. 94 (2014), 586–598.
48. Fu, J., Wolfs, M.G., Deelen, P., Westra, H.J., Fehrmann, R.S., Te Meerman, G.J., Buurman, W.A., Rensen, S.S., Groen, H.J., Weersma, R.K., et al. Unraveling the regulatory mechanisms underlying tissue-dependent genetic variation of gene expression. PLoS Genet., 8, 2012, e1002431.
49. Nicolae, D.L., Gamazon, E., Zhang, W., Duan, S., Dolan, M.E., Cox, N.J., Trait-associated SNPs are more likely to be eQTLs: annotation to enhance discovery from GWAS. PLoS Genet., 6, 2010, e1000888.
50. Battle, A., Khan, Z., Wang, S.H., Mitrano, A., Ford, M.J., Pritchard, J.K., Gilad, Y., Genomic variation. Impact of regulatory variation from RNA to protein. Science 347 (2015), 664–667.
51. Hause, R.J., Stark, A.L., Antao, N.N., Gorsic, L.K., Chung, S.H., Brown, C.D., Wong, S.S., Gill, D.F., Myers, J.L., To, L.A., et al. Identification and validation of genetic variants that influence transcription factor and cell signaling protein levels. Am. J. Hum. Genet. 95 (2014), 194–208.
52. Wu, L., Candille, S.I., Choi, Y., Xie, D., Jiang, L., Li-Pook-Than, J., Tang, H., Snyder, M., Variation and genetic control of protein abundance in humans. Nature 499 (2013), 79–82.
53. Cooper, G.M., Shendure, J., Needles in stacks of needles: finding disease-causal variants in a wealth of genomic data. Nat. Rev. Genet. 12 (2011), 628–640.
54. Vicente, C.T., Edwards, S.L., Hillman, K.M., Kaufmann, S., Mitchell, H., Bain, L., Glubb, D.M., Lee, J.S., French, J.D., Ferreira, M.A., Long-range modulation of PAG1 expression by 8q21 allergy risk variants. Am. J. Hum. Genet. 97 (2015), 329–336.
55. Wang, X., Tucker, N.R., Rizki, G., Mills, R., Krijger, P.H., de Wit, E., Subramanian, V., Bartell, E., Nguyen, X.X., Ye, J., et al. Discovery and validation of sub-threshold genome-wide association study loci using epigenomic signatures. eLife, 5, 2016, e10557.
56. Tak, Y.G., Farnham, P.J., Making sense of GWAS: Using epigenomics and genome engineering to understand the functional relevance of SNPs in non-coding regions of the human genome. Epigenetics Chromatin, 8, 2015 57-015-0050-4. eCollection 2015.
57. Heinz, S., Romanoski, C.E., Benner, C., Glass, C.K., The selection and function of cell type-specific enhancers. Nat. Rev. Mol. Cell Biol. 16 (2015), 144–154.
58. Inoue, F., Ahituv, N., Decoding enhancers using massively parallel reporter assays. Genomics 106 (2015), 159–164.
59. Brown, C.D., Mangravite, L.M., Engelhardt, B.E., Integrative modeling of eQTLs and cis-regulatory elements suggests mechanisms underlying cell type specificity of eQTLs. PLoS Genet., 9, 2013, e1003649.
60. Engel, K.L., Mackiewicz, M., Hardigan, A.A., Myers, R.M., Savic, D., Decoding transcriptional enhancers: Evolving from annotation to functional interpretation. Semin. Cell Dev. Biol. 57 (2016), 40–50.
61. Gaj, T., Sirk, S.J., Shui, S.L., Liu, J., Genome-editing technologies: Principles and applications. Cold Spring Harb. Perspect. Biol., 8, 2016, a023754, 10.1101/cshperspect.a023754.
62. Bauer, D.E., Kamran, S.C., Lessard, S., Xu, J., Fujiwara, Y., Lin, C., Shao, Z., Canver, M.C., Smith, E.C., Pinello, L., et al. An erythroid enhancer of BCL11A subject to genetic variation determines fetal hemoglobin level. Science 342 (2013), 253–257.
63. Lettre, G., Bauer, D.E., Fetal haemoglobin in sickle-cell disease: from genetic epidemiology to new therapeutic strategies. Lancet 387 (2016), 2554–2564.
64. Huang, Q., Whitington, T., Gao, P., Lindberg, J.F., Yang, Y., Sun, J., Väisänen, M.R., Szulkin, R., Annala, M., Yan, J., et al. A prostate cancer susceptibility allele at 6q22 increases RFX6 expression by modulating HOXB13 chromatin binding. Nat. Genet. 46 (2014), 126–135.
65. Spisák, S., Lawrenson, K., Fu, Y., Csabai, I., Cottman, R.T., Seo, J.H., Haiman, C., Han, Y., Lenci, R., Li, Q., et al., GAME-ON/ELLIPSE Consortium. CAUSEL: an epigenome- and genome-editing pipeline for establishing function of noncoding GWAS variants. Nat. Med. 21 (2015), 1357–1363.
66. Mendenhall, E.M., Williamson, K.E., Reyon, D., Zou, J.Y., Ram, O., Joung, J.K., Bernstein, B.E., Locus-specific editing of histone modifications at endogenous enhancers. Nat. Biotechnol. 31 (2013), 1133–1136.
67. Dominguez, A.A., Lim, W.A., Qi, L.S., Beyond editing: repurposing CRISPR-Cas9 for precision genome regulation and interrogation. Nat. Rev. Mol. Cell Biol. 17 (2016), 5–15.
68. Soldner, F., Stelzer, Y., Shivalila, C.S., Abraham, B.J., Latourelle, J.C., Barrasa, M.I., Goldmann, J., Myers, R.H., Young, R.A., Jaenisch, R., Parkinson-associated risk variant in distal enhancer of α-synuclein modulates target gene expression. Nature 533 (2016), 95–99.
69. Singleton, A.B., Farrer, M., Johnson, J., Singleton, A., Hague, S., Kachergus, J., Hulihan, M., Peuralinna, T., Dutra, A., Nussbaum, R., et al. alpha-Synuclein locus triplication causes Parkinson's disease. Science, 302, 2003, 841.
70. Corradin, O., Saiakhova, A., Akhtar-Zaidi, B., Myeroff, L., Willis, J., Cowper-Sal lari, R., Lupien, M., Markowitz, S., Scacheri, P.C., Combinatorial effects of multiple enhancer variants in linkage disequilibrium dictate levels of gene expression to confer susceptibility to common traits. Genome Res. 24 (2014), 1–13.
71. Pombo, A., Dillon, N., Three-dimensional genome architecture: players and mechanisms. Nat. Rev. Mol. Cell Biol. 16 (2015), 245–257.
72. Denker, A., de Laat, W., The second decade of 3C technologies: detailed insights into nuclear organization. Genes Dev. 30 (2016), 1357–1382.
73. Smemo, S., Tena, J.J., Kim, K.H., Gamazon, E.R., Sakabe, N.J., Gómez-Marín, C., Aneas, I., Credidio, F.L., Sobreira, D.R., Wasserman, N.F., et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507 (2014), 371–375.
74. Berndt, S.I., Gustafsson, S., Mägi, R., Ganna, A., Wheeler, E., Feitosa, M.F., Justice, A.E., Monda, K.L., Croteau-Chonka, D.C., Day, F.R., et al. Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture. Nat. Genet. 45 (2013), 501–512.
75. Church, C., Moir, L., McMurray, F., Girard, C., Banks, G.T., Teboul, L., Wells, S., Brüning, J.C., Nolan, P.M., Ashcroft, F.M., Cox, R.D., Overexpression of Fto leads to increased food intake and results in obesity. Nat. Genet. 42 (2010), 1086–1092.
76. Fischer, J., Koch, L., Emmerling, C., Vierkotten, J., Peters, T., Brüning, J.C., Rüther, U., Inactivation of the Fto gene protects from obesity. Nature 458 (2009), 894–898.
77. Gao, X., Shin, Y.H., Li, M., Wang, F., Tong, Q., Zhang, P., The fat mass and obesity associated gene FTO functions in the brain to regulate postnatal growth in mice. PLoS ONE, 5, 2010, e14005.
78. Claussnitzer, M., Dankel, S.N., Kim, K.H., Quon, G., Meuleman, W., Haugen, C., Glunk, V., Sousa, I.S., Beaudry, J.L., Puviindran, V., et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373 (2015), 895–907.
79. Dixon, J.R., Jung, I., Selvaraj, S., Shen, Y., Antosiewicz-Bourget, J.E., Lee, A.Y., Ye, Z., Kim, A., Rajagopal, N., Xie, W., et al. Chromatin architecture reorganization during stem cell differentiation. Nature 518 (2015), 331–336.
80. Holwerda, S.J., van de Werken, H.J., Ribeiro de Almeida, C., Bergen, I.M., de Bruijn, M.J., Verstegen, M.J., Simonis, M., Splinter, E., Wijchers, P.J., Hendriks, R.W., de Laat, W., Allelic exclusion of the immunoglobulin heavy chain locus is independent of its nuclear localization in mature B cells. Nucleic Acids Res. 41 (2013), 6905–6916.
81. Stadhouders, R., Aktuna, S., Thongjuea, S., Aghajanirefah, A., Pourfarzad, F., van Ijcken, W., Lenhard, B., Rooks, H., Best, S., Menzel, S., et al. HBS1L-MYB intergenic variants modulate fetal hemoglobin via long-range MYB enhancers. J. Clin. Invest. 124 (2014), 1699–1710.
82. Tang, Z., Luo, O.J., Li, X., Zheng, M., Zhu, J.J., Szalaj, P., Trzaskoma, P., Magalska, A., Wlodarczyk, J., Ruszczycki, B., et al. CTCF-mediated human 3D genome architecture reveals chromatin topology for transcription. Cell 163 (2015), 1611–1627.
83. Dunning, A.M., Michailidou, K., Kuchenbaecker, K.B., Thompson, D., French, J.D., Beesley, J., Healey, C.S., Kar, S., Pooley, K.A., Lopez-Knowles, E., et al. EMBRACE GEMO Study Collaborators HEBON, kConFab Investigators. Breast cancer risk variants at 6q25 display different phenotype associations and regulate ESR1, RMND1 and CCDC170. Nat. Genet. 48 (2016), 374–386.
84. Ghoussaini, M., Edwards, S.L., Michailidou, K., Nord, S., Cowper-Sal Lari, R., Desai, K., Kar, S., Hillman, K.M., Kaufmann, S., Glubb, D.M., et al. Australian Ovarian Cancer Management Group, Australian Ovarian Cancer Management Group. Evidence that breast cancer risk at the 2q35 locus is mediated through IGFBP5 regulation. Nat. Commun., 4, 2014, 4999.
85. Gallagher, M.D., Posavi, M., Huang, P., Unger, T.L., Berlyand, Y., Gruenewald, A.L., Chesi, A., Manduchi, E., Wells, A.D., Grant, S.F.A., et al. A dementia-associated risk variant near TMEM106B alters chromatin architecture and gene expression. Am. J. Hum. Genet. 101 (2017), 643–663.
86. Hughes, J.R., Roberts, N., McGowan, S., Hay, D., Giannoulatou, E., Lynch, M., De Gobbi, M., Taylor, S., Gibbons, R., Higgs, D.R., Analysis of hundreds of cis-regulatory landscapes at high resolution in a single, high-throughput experiment. Nat. Genet. 46 (2014), 205–212.
87. Maurano, M.T., Haugen, E., Sandstrom, R., Vierstra, J., Shafer, A., Kaul, R., Stamatoyannopoulos, J.A., Large-scale identification of sequence variants influencing human transcription factor occupancy in vivo. Nat. Genet. 47 (2015), 1393–1401.
88. Hellman, L.M., Fried, M.G., Electrophoretic mobility shift assay (EMSA) for detecting protein-nucleic acid interactions. Nat. Protoc. 2 (2007), 1849–1861.
89. Stead, J.A., Keen, J.N., McDowall, K.J., The identification of nucleic acid-interacting proteins using a simple proteomics-based approach that directly incorporates the electrophoretic mobility shift assay. Mol. Cell. Proteomics 5 (2006), 1697–1702.
90. Fogarty, M.P., Cannon, M.E., Vadlamudi, S., Gaulton, K.J., Mohlke, K.L., Identification of a regulatory variant that binds FOXA1 and FOXA2 at the CDC123/CAMK1D type 2 diabetes GWAS locus. PLoS Genet., 10, 2014, e1004633.
91. Kapoor, A., Sekar, R.B., Hansen, N.F., Fox-Talbot, K., Morley, M., Pihur, V., Chatterjee, S., Brandimarto, J., Moravec, C.S., Pulit, S.L., et al., QT Interval-International GWAS Consortium. An enhancer polymorphism at the cardiomyocyte intercalated disc protein NOS1AP locus is a major regulator of the QT interval. Am. J. Hum. Genet. 94 (2014), 854–869.
92. Visser, M., Kayser, M., Palstra, R.J., HERC2 rs12913832 modulates human pigmentation by attenuating chromatin-loop formation between a long-range enhancer and the OCA2 promoter. Genome Res. 22 (2012), 446–455.
93. Spillantini, M.G., Schmidt, M.L., Lee, V.M., Trojanowski, J.Q., Jakes, R., Goedert, M., Alpha-synuclein in Lewy bodies. Nature 388 (1997), 839–840.
94. Polymeropoulos, M.H., Lavedan, C., Leroy, E., Ide, S.E., Dehejia, A., Dutra, A., Pike, B., Root, H., Rubenstein, J., Boyer, R., et al. Mutation in the alpha-synuclein gene identified in families with Parkinson's disease. Science 276 (1997), 2045–2047.
95. Boyle, E.A., Li, Y.I., Pritchard, J.K., An expanded view of complex traits: From polygenic to omnigenic. Cell 169 (2017), 1177–1186.
96. Van Deerlin, V.M., Sleiman, P.M., Martinez-Lage, M., Chen-Plotkin, A., Wang, L.S., Graff-Radford, N.R., Dickson, D.W., Rademakers, R., Boeve, B.F., Grossman, M., et al. Common variants at 7p21 are associated with frontotemporal lobar degeneration with TDP-43 inclusions. Nat. Genet. 42 (2010), 234–239.
97. Finch, N., Carrasquillo, M.M., Baker, M., Rutherford, N.J., Coppola, G., Dejesus-Hernandez, M., Crook, R., Hunter, T., Ghidoni, R., Benussi, L., et al. TMEM106B regulates progranulin levels and the penetrance of FTLD in GRN mutation carriers. Neurology 76 (2011), 467–474.
98. van der Zee, J., Van Langenhove, T., Kleinberger, G., Sleegers, K., Engelborghs, S., Vandenberghe, R., Santens, P., Van den Broeck, M., Joris, G., Brys, J., et al. TMEM106B is associated with frontotemporal lobar degeneration in a clinically diagnosed patient cohort. Brain 134 (2011), 808–815.
99. Chen-Plotkin, A.S., Unger, T.L., Gallagher, M.D., Bill, E., Kwong, L.K., Volpicelli-Daley, L., Busch, J.I., Akle, S., Grossman, M., Van Deerlin, V., et al. TMEM106B, the risk gene for frontotemporal dementia, is regulated by the microRNA-132/212 cluster and affects progranulin pathways. J. Neurosci. 32 (2012), 11213–11227.
100. Brady, O.A., Zheng, Y., Murphy, K., Huang, M., Hu, F., The frontotemporal lobar degeneration risk factor, TMEM106B, regulates lysosomal morphology and function. Hum. Mol. Genet. 22 (2013), 685–695.
101. Busch, J.I., Unger, T.L., Jain, N., Tyler Skrinak, R., Charan, R.A., Chen-Plotkin, A.S., Increased expression of the frontotemporal dementia risk factor TMEM106B causes C9orf72-dependent alterations in lysosomes. Hum. Mol. Genet. 25 (2016), 2681–2697.
102. Stagi, M., Klein, Z.A., Gould, T.J., Bewersdorf, J., Strittmatter, S.M., Lysosome size, motility and stress response regulated by fronto-temporal dementia modifier TMEM106B. Mol. Cell. Neurosci. 61 (2014), 226–240.
103. Cruchaga, C., Graff, C., Chiang, H.H., Wang, J., Hinrichs, A.L., Spiegel, N., Bertelsen, S., Mayo, K., Norton, J.B., Morris, J.C., Goate, A., Association of TMEM106B gene polymorphism with age at onset in granulin mutation carriers and plasma granulin protein levels. Arch. Neurol. 68 (2011), 581–586.
104. Gallagher, M.D., Suh, E., Grossman, M., Elman, L., McCluskey, L., Van Swieten, J.C., Al-Sarraj, S., Neumann, M., Gelpi, E., Ghetti, B., et al. TMEM106B is a genetic modifier of frontotemporal lobar degeneration with C9orf72 hexanucleotide repeat expansions. Acta Neuropathol. 127 (2014), 407–418.
105. Vass, R., Ashbridge, E., Geser, F., Hu, W.T., Grossman, M., Clay-Falcone, D., Elman, L., McCluskey, L., Lee, V.M., Van Deerlin, V.M., et al. Risk genotypes at TMEM106B are associated with cognitive impairment in amyotrophic lateral sclerosis. Acta Neuropathol. 121 (2011), 373–380.
106. Rhinn, H., Abeliovich, A., Differential aging analysis in human cerebral cortex identifies variants in TMEM106B and GRN that regulate aging phenotypes. Cell Syst. 4 (2017), 404–415.e5.
107. White, C.C., Yang, H.S., Yu, L., Chibnik, L.B., Dawe, R.J., Yang, J., Klein, H.U., Felsky, D., Ramos-Miguel, A., Arfanakis, K., et al. Identification of genes associated with dissociation of cognitive performance and neuropathological burden: Multistep analysis of genetic, epigenetic, and transcriptional data. PLoS Med., 14, 2017, e1002287.